These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 446919)

  • 1. Ethnic variability in the plasma insulin response to oral glucose in Polynesian and Micronesian subjects.
    Zimmet P; Whitehouse S; Kiss J
    Diabetes; 1979 Jul; 28(7):624-8. PubMed ID: 446919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between glycaemic abnormalities, obesity and insulin resistance in nondiabetic Polynesians of New Caledonia.
    Defay R; Jaussent I; Lacroux A; Fontbonne A
    Int J Obes (Lond); 2007 Jan; 31(1):109-13. PubMed ID: 16703003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
    Robertson DA; Singh BM; Nattrass M
    Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting fasting serum C-peptide levels in Micronesians: comparison with a Caucasoid population.
    Garcia-Webb P; Zimmet P; Bonser A; King H; Bottomley S
    Diabetologia; 1984 Jul; 27(1):23-6. PubMed ID: 6468796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc status in plasma of obese individuals during glucose administration.
    Chen MD; Lin PY; Sheu WH
    Biol Trace Elem Res; 1997; 60(1-2):123-9. PubMed ID: 9404681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations.
    Golay A; Swislocki AL; Chen YD; Jaspan JB; Reaven GM
    J Clin Endocrinol Metab; 1986 Aug; 63(2):481-4. PubMed ID: 3522620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral L-carnitine supplementation on insulin sensitivity indices in response to glucose feeding in lean and overweight/obese males.
    Galloway SD; Craig TP; Cleland SJ
    Amino Acids; 2011 Jul; 41(2):507-15. PubMed ID: 20963457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of diabetes and its macrovascular manifestations in Pacific populations: the medical effects of social progress.
    Zimmet P
    Diabetes Care; 1979; 2(2):144-53. PubMed ID: 520118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple skinfold-thickness measurements complement conventional anthropometric assessments in predicting glucose tolerance.
    Sievenpiper JL; Jenkins DJ; Josse RG; Leiter LA; Vuksan V
    Am J Clin Nutr; 2001 Mar; 73(3):567-73. PubMed ID: 11237933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?
    Bonora E; Zavaroni I; Bruschi F; Alpi O; Pezzarossa A; Guerra L; Dall'Aglio E; Coscelli C; Butturini U
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1121-7. PubMed ID: 6386838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and chronic effects of dexfenfluramine on glucose and insulin response to intravenous glucose in diabetic and non-diabetic obese subjects.
    Glaser B; Raveh Y; Norynberg C; Berry E; Lavielle R; Nathan C; Cerasi E
    Diabetes Res; 1992; 19(4):165-76. PubMed ID: 1343113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin levels and the natural history of glucose intolerance in Nauruans.
    Dowse GK; Zimmet PZ; Collins VR
    Diabetes; 1996 Oct; 45(10):1367-72. PubMed ID: 8826973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
    Hussein MS; Abushady MM; Refaat S; Ibrahim R
    Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperinsulinemia and hypoinsulinemai. Insulin responses to oral carbohydrate over a wide spectrum of glucose tolerance.
    Savage PJ; Dippe SE; Bennett PH; Gorden P; Roth J; Rushforth NB; Miller M
    Diabetes; 1975 Apr; 24(4):362-8. PubMed ID: 1132602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bimodality of fasting and two-hour glucose tolerance distributions in a Micronesian population.
    Zimmet P; Whitehouse S
    Diabetes; 1978 Aug; 27(8):793-800. PubMed ID: 680406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies of insulinemia in obese patients].
    Jakubczyk D
    Rocz Akad Med Bialymst (1989); 1990-1991; 35-36():21-42. PubMed ID: 2136545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
    Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
    Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
    Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.